OPTOMED.HEOPTOMED.HEHEL
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+14.5%
5Y CAGR+2.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+14.5%/yr
vs +29.5%/yr prior
5Y CAGR
+2.0%/yr
Recent acceleration
Acceleration
-15.0pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 73.35% |
| Q3 2025 | 48.52% |
| Q2 2025 | -436.83% |
| Q1 2025 | -38.98% |
| Q4 2024 | 84.02% |
| Q3 2024 | -68.74% |
| Q2 2024 | -4.29% |
| Q1 2024 | -0.87% |
| Q4 2023 | -788.74% |
| Q3 2023 | 113.29% |
| Q2 2023 | -15.33% |
| Q1 2023 | -47.90% |
| Q4 2022 | 48.85% |
| Q3 2022 | 27.26% |
| Q2 2022 | -15.71% |
| Q1 2022 | -13.33% |
| Q4 2021 | 3.12% |
| Q3 2021 | 25.49% |
| Q2 2021 | -132.31% |
| Q1 2021 | -203.73% |
| Q4 2020 | 66.42% |
| Q3 2020 | -162.50% |
| Q2 2020 | 90.71% |
| Q1 2020 | -305.65% |
| Q4 2019 | 288.40% |
| Q3 2019 | 21.10% |
| Q2 2019 | -13.33% |
| Q1 2019 | -215.67% |
| Q4 2018 | 396.01% |
| Q3 2018 | 0.00% |